Back
China Power International Development 10K Form
Buy
62
CPWIF
China Power International Development
Last Price:
0.44
Seasonality Move:
31.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CPWIF News And Ratings
See the #1 stock for the next 7 days that we like better than CPWIF
CPWIF Financial Statistics
Sales & Book Value
| Annual Sales: | $6.26B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.61 |
| Price / Book: | 0.71 |
Profitability
| EPS (TTM): | 0.04030 |
|---|---|
| Net Income (TTM): | $561.14M |
| Gross Margin: | $3.33B |
| Return on Equity: | 4.49% |
| Return on Assets: | 1.42% |
China Power International Development Earnings Forecast
Key China Power International Development Financial Ratios
- The Gross Profit Margin over the past 19 years for CPWIF is 53.28%.
- The Selling, General & Administrative Expenses for CPWIF have been equal to 1.61% of Gross Profit Margin.
- The Research & Development expenses have been 0.69% of Revenue.
- The Interest Expense is 137.58% of Operating Income.
- The Net Earning history of CPWIF is 6.97% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 10 years.
China Power International Development Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Independent Power & Renewable Electricity Producer |
| Sector: | Utilities |
| Current Symbol: | CPWIF |
| Website: | chinapower.hk |
Debt
| Debt-to-Equity Ratio: | 3.25 |
|---|---|
| Current Ratio: | 0.61 |
| Quick Ratio: | 0.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.02 |
|---|---|
| Forward P/E Ratio: | 0 |
CPWIF Technical Analysis vs Fundamental Analysis
Buy
62
China Power International Development (CPWIF)
is a Buy
Is China Power International Development a Buy or a Sell?
-
China Power International Development stock is rated a Buy
The current China Power International Development [CPWIF] share price is $0.44. The Score for CPWIF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.